Joe Fletcher | executive |
David Ricks | executive |
Anat Ashkenazi | executive |
Daniel Skovronsky | executive |
Terence Flynn | analyst |
Ilya Yuffa | executive |
Christopher Schott | analyst |
Patrik Jonsson | executive |
Seamus Fernandez | analyst |
Umer Raffat | analyst |
Timothy Anderson | analyst |
Mohit Bansal | analyst |
Louise Chen | analyst |
Kerry Holford | analyst |
Geoffrey Meacham | analyst |
David Risinger | analyst |
Evan Seigerman | analyst |
Steve Scala | analyst |
Chris Shibutani | analyst |
Akash Tewari | analyst |
Trung Huynh | analyst |
Carter L. Gould | analyst |
James Shin | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2023 Earnings Call. [Operator Instructions] I would now like to turn the conference over to your host, Joe Fletcher, Senior Vice President of Investor Relations. Please go ahead.
Good morning, and thank you, Paul, and thanks for joining us for Eli Lilly and Company's Q4 2023 Earnings and 2024 Guidance Call. I'm Joe Fletcher, Senior President of Investor Relations.